- Home
- BCDA vs EPWK Comparison
BCDA vs EPWK Comparison
Compare BCDA & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- EPWK
- Stock Information
- Founded
- BCDA N/A
- EPWK 2011
- Country
- BCDA United States
- EPWK China
- Employees
- BCDA N/A
- EPWK N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- EPWK
- Sector
- BCDA Health Care
- EPWK
- Exchange
- BCDA Nasdaq
- EPWK Nasdaq
- Market Cap
- BCDA 11.0M
- EPWK 11.0M
- IPO Year
- BCDA N/A
- EPWK 2025
- Fundamental
- Price
- BCDA $2.12
- EPWK $0.52
- Analyst Decision
- BCDA Strong Buy
- EPWK
- Analyst Count
- BCDA 1
- EPWK 0
- Target Price
- BCDA $25.00
- EPWK N/A
- AVG Volume (30 Days)
- BCDA 204.0K
- EPWK 3.1M
- Earning Date
- BCDA 08-12-2025
- EPWK 05-27-2025
- Dividend Yield
- BCDA N/A
- EPWK N/A
- EPS Growth
- BCDA N/A
- EPWK N/A
- EPS
- BCDA N/A
- EPWK N/A
- Revenue
- BCDA $3,000.00
- EPWK $20,164,008.00
- Revenue This Year
- BCDA N/A
- EPWK N/A
- Revenue Next Year
- BCDA N/A
- EPWK N/A
- P/E Ratio
- BCDA N/A
- EPWK N/A
- Revenue Growth
- BCDA N/A
- EPWK 10.25
- 52 Week Low
- BCDA $1.63
- EPWK $0.41
- 52 Week High
- BCDA $4.66
- EPWK $26.00
- Technical
- Relative Strength Index (RSI)
- BCDA 44.60
- EPWK N/A
- Support Level
- BCDA $1.98
- EPWK N/A
- Resistance Level
- BCDA $2.45
- EPWK N/A
- Average True Range (ATR)
- BCDA 0.16
- EPWK 0.00
- MACD
- BCDA -0.01
- EPWK 0.00
- Stochastic Oscillator
- BCDA 18.00
- EPWK 0.00
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.